GlaxoSmithKline sales and marketing update

GlaxoSmithKline lowered the price of its Cervarix cervical cancer vaccine by 30% to C$90 (US$88.41) per dose from C$134.95 (US$132.56) per dose in Canada after market research showed that the high p...